PolyTherics and Egypt's Minapharm enter PEG-based collaboration
This article was originally published in Scrip
Executive Summary
PolyTherics of the UK is to apply its drug modification technologies to a target protein of interest to Egyptian pharmaceutical company Minapharm Pharmaceuticals.